Global Sickle Cell Disease Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Sickle Cell Disease Drug

• 1.1 Definition of Sickle Cell Disease Drug
• 1.2 Sickle Cell Disease Drug Segment by Type
  • 1.2.1 Global Sickle Cell Disease Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 ARQ-092
  • 1.2.3 BIVV-003
  • 1.2.4 CAL-H
  • 1.2.5 CTX-001
  • 1.2.6 DRX-194
  • 1.2.7 Others
• 1.3 Sickle Cell Disease Drug Segment by Applications
  • 1.3.1 Global Sickle Cell Disease Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Sickle Cell Disease Drug Overall Market
  • 1.4.1 Global Sickle Cell Disease Drug Revenue (2014-2025)
  • 1.4.2 Global Sickle Cell Disease Drug Production (2014-2025)
  • 1.4.3 North America Sickle Cell Disease Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Sickle Cell Disease Drug Status and Prospect (2014-2025)
  • 1.4.5 China Sickle Cell Disease Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Sickle Cell Disease Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Sickle Cell Disease Drug Status and Prospect (2014-2025)
  • 1.4.8 India Sickle Cell Disease Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Sickle Cell Disease Drug
• 2.3 Manufacturing Process Analysis of Sickle Cell Disease Drug
• 2.4 Industry Chain Structure of Sickle Cell Disease Drug

3 Development and Manufacturing Plants Analysis of Sickle Cell Disease Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Sickle Cell Disease Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Sickle Cell Disease Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Sickle Cell Disease Drug Production and Capacity Analysis
• 4.2 Sickle Cell Disease Drug Revenue Analysis
• 4.3 Sickle Cell Disease Drug Price Analysis
• 4.4 Market Concentration Degree

5 Sickle Cell Disease Drug Regional Market Analysis

• 5.1 Sickle Cell Disease Drug Production by Regions
  • 5.1.1 Global Sickle Cell Disease Drug Production by Regions
  • 5.1.2 Global Sickle Cell Disease Drug Revenue by Regions
• 5.2 Sickle Cell Disease Drug Consumption by Regions
• 5.3 North America Sickle Cell Disease Drug Market Analysis
  • 5.3.1 North America Sickle Cell Disease Drug Production
  • 5.3.2 North America Sickle Cell Disease Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Sickle Cell Disease Drug Import and Export
• 5.4 Europe Sickle Cell Disease Drug Market Analysis
  • 5.4.1 Europe Sickle Cell Disease Drug Production
  • 5.4.2 Europe Sickle Cell Disease Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Sickle Cell Disease Drug Import and Export
• 5.5 China Sickle Cell Disease Drug Market Analysis
  • 5.5.1 China Sickle Cell Disease Drug Production
  • 5.5.2 China Sickle Cell Disease Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Sickle Cell Disease Drug Import and Export
• 5.6 Japan Sickle Cell Disease Drug Market Analysis
  • 5.6.1 Japan Sickle Cell Disease Drug Production
  • 5.6.2 Japan Sickle Cell Disease Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Sickle Cell Disease Drug Import and Export
• 5.7 Southeast Asia Sickle Cell Disease Drug Market Analysis
  • 5.7.1 Southeast Asia Sickle Cell Disease Drug Production
  • 5.7.2 Southeast Asia Sickle Cell Disease Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Sickle Cell Disease Drug Import and Export
• 5.8 India Sickle Cell Disease Drug Market Analysis
  • 5.8.1 India Sickle Cell Disease Drug Production
  • 5.8.2 India Sickle Cell Disease Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Sickle Cell Disease Drug Import and Export

6 Sickle Cell Disease Drug Segment Market Analysis (by Type)

• 6.1 Global Sickle Cell Disease Drug Production by Type
• 6.2 Global Sickle Cell Disease Drug Revenue by Type
• 6.3 Sickle Cell Disease Drug Price by Type

7 Sickle Cell Disease Drug Segment Market Analysis (by Application)

• 7.1 Global Sickle Cell Disease Drug Consumption by Application
• 7.2 Global Sickle Cell Disease Drug Consumption Market Share by Application (2014-2019)

8 Sickle Cell Disease Drug Major Manufacturers Analysis

• 8.1 Acceleron Pharma Inc
  • 8.1.1 Acceleron Pharma Inc Sickle Cell Disease Drug Production Sites and Area Served
  • 8.1.2 Acceleron Pharma Inc Product Introduction, Application and Specification
  • 8.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Addmedica SAS
  • 8.2.1 Addmedica SAS Sickle Cell Disease Drug Production Sites and Area Served
  • 8.2.2 Addmedica SAS Product Introduction, Application and Specification
  • 8.2.3 Addmedica SAS Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Angiocrine Bioscience Inc
  • 8.3.1 Angiocrine Bioscience Inc Sickle Cell Disease Drug Production Sites and Area Served
  • 8.3.2 Angiocrine Bioscience Inc Product Introduction, Application and Specification
  • 8.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Annexin Pharmaceuticals AB
  • 8.4.1 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production Sites and Area Served
  • 8.4.2 Annexin Pharmaceuticals AB Product Introduction, Application and Specification
  • 8.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 ArQule Inc
  • 8.5.1 ArQule Inc Sickle Cell Disease Drug Production Sites and Area Served
  • 8.5.2 ArQule Inc Product Introduction, Application and Specification
  • 8.5.3 ArQule Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Bio Products Laboratory Ltd
  • 8.6.1 Bio Products Laboratory Ltd Sickle Cell Disease Drug Production Sites and Area Served
  • 8.6.2 Bio Products Laboratory Ltd Product Introduction, Application and Specification
  • 8.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Bioverativ Inc
  • 8.7.1 Bioverativ Inc Sickle Cell Disease Drug Production Sites and Area Served
  • 8.7.2 Bioverativ Inc Product Introduction, Application and Specification
  • 8.7.3 Bioverativ Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 bluebird bio Inc
  • 8.8.1 bluebird bio Inc Sickle Cell Disease Drug Production Sites and Area Served
  • 8.8.2 bluebird bio Inc Product Introduction, Application and Specification
  • 8.8.3 bluebird bio Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Bristol-Myers Squibb Co
  • 8.9.1 Bristol-Myers Squibb Co Sickle Cell Disease Drug Production Sites and Area Served
  • 8.9.2 Bristol-Myers Squibb Co Product Introduction, Application and Specification
  • 8.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Calimmune Inc
  • 8.10.1 Calimmune Inc Sickle Cell Disease Drug Production Sites and Area Served
  • 8.10.2 Calimmune Inc Product Introduction, Application and Specification
  • 8.10.3 Calimmune Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 CRISPR Therapeutics
• 8.12 CSL Ltd
• 8.13 Daiichi Sankyo Co Ltd
• 8.14 Editas Medicine Inc
• 8.15 Errant Gene Therapeutics LLC
• 8.16 Gamida Cell Ltd
• 8.17 Genethon SA
• 8.18 Gilead Sciences Inc
• 8.19 Global Blood Therapeutics Inc

9 Development Trend of Analysis of Sickle Cell Disease Drug Market

• 9.1 Global Sickle Cell Disease Drug Market Trend Analysis
  • 9.1.1 Global Sickle Cell Disease Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Sickle Cell Disease Drug Regional Market Trend
  • 9.2.1 North America Sickle Cell Disease Drug Forecast 2019-2025
  • 9.2.2 Europe Sickle Cell Disease Drug Forecast 2019-2025
  • 9.2.3 China Sickle Cell Disease Drug Forecast 2019-2025
  • 9.2.4 Japan Sickle Cell Disease Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Sickle Cell Disease Drug Forecast 2019-2025
  • 9.2.6 India Sickle Cell Disease Drug Forecast 2019-2025
• 9.3 Sickle Cell Disease Drug Market Trend (Product Type)
• 9.4 Sickle Cell Disease Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Sickle Cell Disease Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List